Concord Corporation made the following purchases of investments during 2023, the first year in which Concord invested in equity securities: 1. On January 15, it purchased 6,390 shares of Nirmala Corp.'s common shares at $23.80 per share plus commission of $1,407. 2. 3. On April 1, it purchased 3,550 shares of Oxana Corp.'s common shares at $37 per share plus commission of $2,393. On September 10, it purchased 4,970 shares of WTA Corp.'s preferred shares at $18.80 per share plus commission of $2,066. On May 20, 2023, Concord sold 2,130 of the Nirmala common shares at a market price of $25 per share less brokerage commissions of $2,027. The year-end fair values per share were as follows: Nirmala $21, Oxana $39, and WTA $20. The chief accountant of Concord tells you that Concord holds these investments with the intention of selling them to earn short-term profits from appreciation in their prices and accounts for them using the FV-NI model. Concord follows IFRS.